The promising drug duo that may improve spinal muscular atrophy treatment
In 2016, Spinraza became a game-changer for spinal muscular atrophy (SMA) patients. It was the first FDA-approved treatment for the neurodegenerative disease, which is the leading genetic cause of infant death. The drug was ...
Jul 13, 2022
0
63
